Emerald Mutual Fund Advisers Trust Chemo Centryx, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

$1.77 Billion
Q3 2024

Shares

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 29, 2021	SELL	$9.59 - $50.88 $2.77 Million - $14.7 Million	-288,980 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$49.53 - $68.4 $5.94 Million - $8.2 Million	-119,848 Reduced 29.32%	288,980 $14.8 Million
Q4 2020 Jan 29, 2021	BUY	$47.25 - $65.16 $2.09 Million - $2.88 Million	44,171 Added 12.11%	408,828 $25.3 Million
Q3 2020 Oct 28, 2020	SELL	$46.35 - $61.69 $556 - $740	-12 Reduced -0.0%	364,657 $20 Million
Q2 2020 Jul 28, 2020	BUY	$38.58 - $65.07 $1.62 Million - $2.73 Million	41,989 Added 13.01%	364,669 $21 Million
Q1 2020 Apr 30, 2020	BUY	$32.73 - $50.78 $5.2 Million - $8.06 Million	158,754 Added 96.84%	322,680 $13 Million
Q4 2019 Jan 29, 2020	BUY	$6.81 - $39.55 $1.12 Million - $6.48 Million	163,926 New	163,926 $6.48 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.